HRES 277 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Supporting the designation of May 2025 as "National Myositis Awareness Month".
Supporting the designation of May 2025 as ``National Myositis Awareness Month''.
Summary
This resolution supports the designation of May 2025 as National Myositis Awareness Month. It recognizes myositis as a rare, chronic autoimmune muscle disease that affects many Americans and acknowledges challenges patients face, including difficulty obtaining diagnoses, limited treatment options, and health disparities affecting women and people of color. The resolution encourages Americans to learn more about myositis and support individuals and families affected by these conditions. As a House resolution, this measure expresses congressional support but does not create binding law or federal requirements.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
2 cosponsors
- Rep. Ellzey, Jake [R-TX-6] (R-TX)
- Rep. Tonko, Paul [D-NY-20] (D-NY)
Money behind the sponsor
Top reported contributors to Richard Mccormick’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $21,624
- INFO REQUESTED $18,600
- CEO $15,700
- EXECUTIVE $12,900
- SANKRANTI / VENSAI TECHNOLOGIES $12,505
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Richard Mccormick → · Outside spending →
Actions (2)
- Mar 31, 2025 Referred to the House Committee on Energy and Commerce. · house
- Mar 31, 2025 Submitted in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE HOUSE OF REPRESENTATIVES
March 31, 2025
Mr. McCormick submitted the following resolution; which was referred to the Committee on Energy and Commerce
RESOLUTION
Supporting the designation of May 2025 as “National Myositis Awareness Month”.
Whereas residents of the United States of America are among those affected by myositis and other rare diseases, with nearly 1 in 10 Americans having rare diseases; Whereas idiopathic inflammatory myopathies (collectively referred to as myositis) are rare, chronic, autoimmune muscle-wasting diseases that often feature debilitating muscle inflammation and other symptoms, such as pain, fatigue, and trouble swallowing, and can result in myositis- associated interstitial lung disease; Whereas more research is needed to identify the causes of and modes of treatments for the myositis group of diseases, which includes anti-MDA5 autoantibody-positive myositis, antisynthetase syndrome, dermatomyositis, juvenile dermatomyositis, immune-mediated necrotizing myopathy, inclusion body myositis, and polymyositis; Whereas myositis is difficult to diagnose which leads myositis patients to frequently experience delayed treatment and difficulty finding a health care provider with expertise in their condition; Whereas all who suffer with myositis experience reduced quality of life, particularly since no cure has been found and life expectancy is shortened, especially for those with inclusion body myositis, and women and people of color with all forms of myositis experience particularly pronounced health disparities; and Whereas public awareness and education campaigns on myositis detection and treatment are held during the month of May: Now, therefore, be it Resolved, That the House of Representatives—
(1) supports the designation of “National Myositis Awareness Month”;
(2) recognizes the importance of raising awareness about myositis and its impact on United States veterans and citizens; and
(3) encourages all people in the United States to become more informed about myositis and to support the individuals and families who are affected by these conditions. <all>
Comments